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Brassinosteroids (BRs) as a class of steroid plant hormones participate in the regulation of
numerous developmental processes, including root and shoot growth, vascular
differentiation, fertility, flowering, and seed germination, as well as in responding to
environmental stresses. During four decades of research, the BR biosynthetic pathways
have been well studied with forward- and reverse genetics approaches. The free BRs
contain 27, 28, and 29 carbons within their skeletal structure: (1): 5a-cholestane or 26-
nor-24a-methyl-5a-cholestane for C27-BRs; (2) 24a-methyl-5a-cholestane, 24b-methyl-
5a-cholestane or 24-methylene-5a-cholestane for C28-BRs; (3) 24a-ethyl-5a-
cholestane, 24(Z)-ethylidene-5a-cholestane, 25-methyl-5a-campestane or 24-
methylene-25-methyl-5a-cholestane for C29-BRs, as well as different kinds and
orientations of oxygenated functions in A- and B-ring. These alkyl substituents are also
common structural features of sterols. BRs are derived from sterols carrying the same side
chain. The C27-BRs without substituent at C-24 are biosynthesized from cholesterol. The
C28-BRs carrying either an a-methyl, b-methyl, or methylene group are derived from
campesterol, 24-epicampesterol or 24-methylenecholesterol, respectively. The C29-BRs
with an a-ethyl group are produced from sitosterol. Furthermore, the C29 BRs carrying
methylene at C-24 and an additional methyl group at C-25 are derived from 24-
methylene-25-methylcholesterol. Generally, BRs are biosynthesized via cycloartenol
and cycloartanol dependent pathways. Till now, more than 17 compounds were
characterized as inhibitors of the BR biosynthesis. For nine of the inhibitors (e.g.,
brassinazole and YCZ-18) a specific target reaction within the BR biosynthetic pathway
has been identified. Therefore, the review highlights comprehensively recent advances in
our understanding of the BR biosynthesis, sterol precursors, and dependencies between
the C27-C28 and C28-C29 pathways.
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Brassinosteroids (BRs) represent the sixth class of plant
hormones. Since the discovery of brassinolide (BL) in 1979,
about 70 naturally occurring compounds from this group have
been reported as free molecules or conjugates with glucose and
fatty acids. BRs are structurally very similar to androgens,
estrogens, corticoids, and ecdysteroids. Their presence was
reported both in lower and higher plants, especially in
angiosperms; and also in all plant organs, including roots,
stems, leaves, flowers, anthers, pollen, seeds, and grain (Bajguz
and Tretyn, 2003; Yokota et al., 2017; Bajguz, 2019; Zullo and
Bajguz, 2019). BRs play an essential role in the development and
growth of plants. They elicit a broad spectrum of morphological
and physiological responses as well as a tolerance against abiotic
and biotic stress (Bajguz and Hayat, 2009; Bajguz and
Piotrowska-Niczyporuk, 2014; Wei and Li, 2016; Wendeborn
et al., 2017; Ahanger et al., 2018; Siddiqui et al., 2018; Nolan
et al., 2020).CHEMICAL STRUCTURE OF BRs
Based on the total number of carbons, BRs are divided into C27,
C28, and C29-type. The basic structure of C27-BRs is a 5a-
cholestane skeleton, C28-BRs: 5a-ergostane, and C29-BRs: 5a-
stigmastane (Figure S1). Differences in the structure of these
hormones are due to the type and orientation of oxygenated
functions in the A- and B-ring, as well as the number and
position of functional groups in the side chain of the molecule.
These modifications arise during oxidation and reduction
reactions. Based on the cholesterol (CR) side chain, BRs are
divided by different substituents into C-23, C-24, C-25, 23-oxo,
24S-methyl, 24R-methyl, 24-methylene, 24S-ethyl, 24-
ethylidene, 24-methylene-25-methyl, 24-methyl-25-methyl;
without substituent at C-23, without substituent at C-24, and
without substituents at C-23, C-24. BRs can also conjugate with
glucose and fatty acids (Fujioka and Yokota, 2003; Bajguz, 2007;
Piotrowska and Bajguz, 2011; Wendeborn et al., 2017; Zullo and
Bajguz, 2019).BRs BIOSYNTHETIC PATHWAYS
Three pathways of the BR biosynthesis leading to the production
of C27-, C28-, or C29-type of BRs are currently known (Figure 1;
Figure S1). Early steps of their synthesis are common for each
type and may occur via mevalonate (MVA) or non-MVA
pathway, while later steps differentiate the BR biosynthesis
pathways (cycloartenol- and cycloartanol-dependent). So far,
most of the reactions, enzymes, and genes were discovered and
characterized by the C28-BR biosynthesis pathway (mostly in
Arabidopsis thaliana, from which the majority of genes in this
pathway were isolated). Their biosynthesis includes two major
stages: biosynthesis of campesterol and 22a-hydroxycampesterol.
The direct substrate of C27-BRs viz. cholesterol (CR) is finallyFrontiers in Plant Science | www.frontiersin.org 2converted to 28-norBL, whereas the biosynthesis of C29-BRs is
initiated from b-sitosterol and leads to 28-homoBL. However, not
all indirect compounds of these two pathways have been identified
(Figure 1; Figure S1) (Fujioka et al., 2002; Kwon and Choe, 2005;
Fujita et al., 2006; Ohnishi et al., 2006b; Chung and Choe, 2013;
Roh et al., 2017; Kim et al., 2018; Rozhon et al., 2019).
Early Steps of BRs Biosynthesis
Biosynthesis of isopentenyl pyrophosphate (IPP), which is an
indirect compound in the CR synthesis pathway, can occur via
two pathways: non-MVA in lower plants and MVA in the most of
higher plants. The initial compounds in non-MVA pathway are
D-glyceraldehyde 3-phosphate and pyruvate, which are
transformed into the 1-deoxy-D-xylulose 5-phosphate (DOXP)
by the DOXP synthase. Then, DOXP is converted to 2-C-methyl-
D-erythritol 4-phosphate (MEP) by the DOXP reductoisomerase.
The next step leads to the formation of 4-(cytidine 5’-diphospho)-
2-C methyl-D-erythritol (CDP-ME) from MEP. The reaction is
catalyzed by the CDP-ME synthase. Then, CDP-ME is converted
to CDP-methyl-D-erythritol-2-phosphate by the CDP-ME kinase,
and the obtained compound is transformed to 2-C-methyl-D-
erythitol-2,4-cyclodiphosphate by the ME cyclodiphosphate
synthase. Finally, with the action of reductases and dehydratases,
the IPP is synthesized (Figure 1; Figure S1) (Lichtenthaler, 2000).
In the MVA pathway, three molecules of acetyl-CoA are
combined to produce 3-hydroxy-3-methyloglutaryl-CoA by the
HMG-CoA synthase. The obtained compound is reduced toMVA
by the HMG-CoA reductase. IPP is synthesized from MVA
through the two indirect phosphorylation intermediates, such as
MVA-phosphate and MVA-pyrophosphate (MVA-PP)
(Miziorko, 2011). Enzymes involved in these reactions are the
MVA kinase, phospho-MVA kinase, and MVA-PP decarboxylase,
respectively (Figure 1; Figure S1) (Wang et al., 2017).
Biochemical changes of IPP via geranyl pyrophosphate and
farnesyl pyrophosphate lead to the synthesis of squalene, which
is oxidized to squalene-2,3-oxide via squalene epoxidase and the
latter is converted to cycloartenol by the cycloartenol synthase.
Cycloartenol is a key compound for the BR biosynthesis because
it constitutes a substrate for multistep reactions in few pathways,
which lead to the synthesis of C27-, C28-, and C29-BRs.
Conversion of cycloartenol via cycloartanol and in a series of
subsequent reactions to cholesterol/cholestanol and/or 6-
oxocholestanol leads to the synthesis of C27-BRs (Figure 1;
Figure S1) (Wang et al., 2017).
Cycloartenol may also be a substrate of the C-24 methylation
reaction, which is catalyzed by the sterol C-24 methyltransferase
(SMT1), and leads to 24-methylenecycloartanol. The next few
reactions are catalyzed by C-4 sterol methyl oxidase (SMO1),
cycloprophylsterol isomerase, obtusifoliol 14a-demethylase
(CYP51), and sterol C-14 reductase, leading to the synthesis of
4a-methylergostatrienol. Indirect products of these reactions are
cycloeucalenol and obtusifoliol. In next step, the sterol C-14
reductase which is encoded by the FACKEL/HYDRA2 gene
catalyzes the reduction of 4a-methylergostatrienol to 4a-
methylergostadienol, which is converted in the subsequent
reaction to 24-methylenelophenol by the sterol 8,7 isomeraseJuly 2020 | Volume 11 | Article 1034
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Wang et al., 2017).
24-methylenelophenol is a substrate of two independent
pathways of sterol biosynthesis. The first leads to the biosynthesis
of isofucosterol/b-sitosterol that are precursors of the C29-BR
biosynthesis (Xin et al., 2016); the second pathway, 24-converts
methylenelophenol to campesterol, which is a substrate of the C28-
BR biosynthesis (Figure 1; Figure S1) (Choe, 2006; Sonawane
et al., 2016).
Biosynthesis of C27-BRs
The C27-BR biosynthesis pathway starts from the conversion of
cycloartenol to cycloartanol (Figure 1; Figure S1) by the sterol side
chain reductase 2 (SSR2) and proceeds through a synthesis of 31-
norcycloartanol from cycloartanol by the C4-sterol methyloxidase3
(SMO3), and further biochemical changes of 31-norcycloartanol
up to 31-nor-24(25)-dihydrolanosterol, 4a-methylcholestadienol,
4a-methyl-24(25)-dihydrozymosterol, 4a-methylcholestenol, 5a-
cholest-7-en-3b-ol, 7-dehydroCR and finally CR, respectively.
The reaction of 5a-cholest-7-en-3b-ol synthesis is catalyzed by
the C4-sterol methyloxidase 4 (SMO4), while sterol C5
(6) desaturase catalyzes synthesis of 7-dehydrocholesterol.
Cholesterol is synthesized from 7-dehydrocholesterol by the 7-
dehydrocholesterol reductase 2 (Sonawane et al., 2016). The
biosynthesis of C27-BRs might occur through the late C6
oxidation pathway. Firstly, cholesterol is converted to cholestanol
(a C27-BR biosynthesis precursor) by the 5a-reductase encoded by
the DET2 gene. The 5a-reductase DET2 belongs to enzymes that
have broad substrate specificity; therefore, it catalyzes reaction
(Figure 1; Figure S1). In the next steps of the C27-BR
biosynthesis pathway 6-deoxo-28-norcathasterone, 6-deoxo-28-
norteasterone, 6-deoxo-28-nor-3-dehydroteasterone, 6-deoxo-28-
nortyphasterol and 6-deoxo-28-norcastasterone are synthesized in
the consecutive reactions. Furthermore, the early C6 oxidation
pathway is initiated through oxidation of cholestanol into 6-
oxocholestanol, which is then followed by a synthesis of 28-
norcathasterone, 28-norteasterone, 28-nor-3-dehydroteasterone,
28-nortyphasterol, 28-norcastasterone, and 28-norbrassinolide.
Enzymatic conversions of compounds from the late C6 oxidation
pathway to the early C6 oxidation counterparts have been
evidenced, e.g. 6-deoxo-28-norteasterone to 28-norteasterone, 6-
deoxo-28-nortyphasterol to 28-nortyphasterol, and 6-deoxo-28-
norcastasterone to 28-norcastasterone. It is known that oxidation/
hydroxylation steps in the all BR biosynthetic pathways are
catalyzed by cytochrome P450 enzymes. The CYP85A1 and
CYP85A2 oxidases, similarly to the 5a-reductase DET2, belong to
enzymes of broad substrate specificity. They catalyze the oxidation
reactions connecting the late and early counterparts of the C27-BR
biosynthesis pathway, and also catalyze corresponding reactions
during the C28-BR pathway (Figure 1; Figure S1) (Kim et al., 2005;
Fujita et al., 2006; Joo et al., 2012; Zhao and Li, 2012; Joo
et al., 2015).
Biosynthesis of C28-BRs
24-methylenelophenol may also be converted to episterol, which
is the first characteristic metabolite in the C28-BR biosynthesis.Frontiers in Plant Science | www.frontiersin.org 4The reaction is catalyzed by the C-4 sterol methyl oxidase 2
(SMO2) (Figure 1; Figure S1). Then, episterol is converted to 5-
dehydroepisterol by the sterol C-5(6) desaturase encoded by the
DWF7 gene (also known as STE1), which is then converted to 24-
methyleneCR (catalyzed by 7-dehydrocholesterol reductase
encoded by the DWF5 gene) (Choe, 2006; Ohnishi, 2018).
Further stages of the C28-BR biosynthesis may proceed
through two parallel pathways, called the late and early C-
22 oxidation pathway. Reduction of 24-methyleneCR to
campesterol initiates the late C-22 oxidation pathway and is
catalyzed by the C-24(25)-sterol reductase in a two-step reaction
in which 24-methyl-desmosterol is an intermediate (Dockter
et al., 2014). The enzyme (also known as sterol side-chain
reductase 1), which catalyzes the production of campesterol, is
encoded by the DWF1 gene. Campesterol is then transformed in
the 5,4 isomerization reaction to (24R)-ergostan-4-en-3b-one.
The latter is then converted through the DET2-mediated 5a-
reduction to (24R)-5a-ergostan-3-one, which is transformed
into campestanol (CN). In the parallel, early C-22 oxidation
pathway, C-22a hydroxylation of 24-methyleneCR leads to the
synthesis of 22-hydroxy-24-methyleneCR. The reaction of C-
22a hydroxylation is catalyzed by the C-22a hydroxylase, which
is encoded by the DWF4 gene. The enzyme belongs to the P450
cytochrome family (Fujiyama et al., 2019). The next reactions are
analogous to the late C-22 oxidation pathway and result in the
synthesis of 22-hydroxy forms of the corresponding compounds.
However, an essential difference between the C-22 oxidation sub-
pathways is the synthesis of 6-deoxocathasterone (6-deoxoCT)
from (22S,24R)-22-hydroxy-5a-ergostan-3-one, without
synthesis of campestanol (CN) (CN-independent pathway of
BRs biosynthesis) as a result of the early C-22 oxidation. On the
other hand, in each stage of the late C-22 oxidation pathway, the
compound can be hydroxylated by the C-22a hydroxylase
into hydroxygenated forms of early C-22 pathway (Choe,
2004; Ohnishi, 2018). Moreover, biochemical changes of 22-
hydroxymethyleneCR can lead to the synthesis of 6-
deoxodolichosterone, which may be further converted into
dolichosterone (DS), and dolicholide (DL), as well as to
castasterone (CS) and BL (Roh et al., 2017).
Campestanol may be a substrate of the BR biosynthesis in a
parallel manner, both in late C6 oxidation pathway (when
hydroxylation of carbon atoms in the A-ring and both C-22 and
C-23 positions of the side chain occurs before oxidation of C6) and
early C-6 oxidation pathway (when hydroxylation takes place after
oxidation of C6) (Figure 1; Figure S1) (Shimada et al., 2001). In A.
thaliana both the early and late C6 oxidation pathways are
functional (Fujioka et al., 2000); however, the late C6 oxidation
pathway plays a prominent role during photomorphogenesis,
whereas the parallel early C6 oxidation dominates during
skotomorphogenesis (Noguchi et al., 2000). Generally, the late
C6 pathway is more prominent in plants (e.g., in potato, it is the
only type of the C28-BR biosynthesis). The late C6 pathway begins
with hydroxylation of CN into the 6-deoxoCT by the 22a-
hydroxylase. 6-deoxoCT may also be synthesized directly from
22-hydroxy5a-ergostan-3-one (the CN-independent pathway).
Then, 6-deoxoCT is hydroxylated through the C-23 hydroxylaseJuly 2020 | Volume 11 | Article 1034
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C-3 oxidized into the 3-dehydro-6-deoxoteasterone (6-deoxo-3-
DT) through the CYP90D C3-oxidase. In the next step, 6-deoxo-3-
DT is converted to 6-deoxoTY. This reaction is catalyzed by the
D11 CYP724B1 enzyme. Then, 6-deoxoTY is hydroxylated to 6-
deoxoCS by the 2a-hydroxylase encoded by the DDWF1 gene. 6-
deoxoCS is converted to castasterone (CS) (BR-6-oxidase1 and BR-
6-oxidase2 catalyze the reaction). Then, CS is converted to BL via
Baeyer-Villiger oxidation by the BR-6-oxidase2 (CYP85A2) (Choe,
2004; Choe, 2006; Vriet et al., 2013; Nakano and Asami, 2014;
Ohnishi, 2018).
The early C6 oxidation pathway begins from hydroxylation of
CN to 6a-hydroxyCN and its subsequent oxidation to 6-oxo-
CN. The latter is transformed to CT by the 22a-hydroxylase.
Cathasterone (CT) is converted in the consecutive reactions to
teasterone (TE), 3-dehydroteasterone (3-DT), typhasterol (TY),
CS, and BL, respectively (Shimada et al., 2001; Fujioka et al.,
2002; Kwon and Choe, 2005; Ohnishi et al., 2006a; Ohnishi et al.,
2006b; Lee et al., 2010; Lee et al., 2011; Zhao and Li, 2012; Chung
and Choe, 2013; Joo et al., 2015; Kim et al., 2018; Ohnishi, 2018;
Roh et al., 2020).
Biosynthesis of C29-BRs
The C29-BR biosynthesis is the least known and described route of
the BR biosynthesis (Figure 1; Figure S1). In this pathway 24-
methylenelophenol is converted by sterol methyltransferase 2
(SMT2) into 24-ethylidenelophenol that is transformed into
avenasterol by the sterol methyl oxidase 2. Then, isofucosterol
and b-sitosterol are produced from avenasterol in a series of
reactions catalyzed by the DWF7, DWF5, and SSR1 (DWF1)
enzymes. b-sitosterol, as a precursor of the C29-BRs, is
hydroxylated into 6-deoxo-28-homoTY and oxygenated into 28-
homoTY by the CYP724B2 and CYP90B3 C-22 hydroxylase,
respectively (Ohnishi et al., 2006a). 28-homoTY can be also
formed from 28-homoTE, but intermediates of this reaction
have not been identified yet. 28-homoTY is converted to 28-
homoCS and 28-homoBL via the CYP85A1/A2 oxidases. The
recent report suggests the way of 28-homodolicholide and CS
synthesis from isofucosterol via 22-hydroxyisofucosterol, 6-deoxo-
28-homoDS, and 28-homoDS, respectively. Moreover, CS can be
converted from b-sitosterol, through the 22-homositosterol, 6-
deoxohomositosterol, and 28-homoCS. It was found that 28-
homoTE, 28-homoTY and 28-homoCS can be converted into
26-nor-28-homoTE, 26-nor-28-homoTY, and 26-nor-28-
homoCS, respectively. C-26 demethylation might also serve to a
deactivation of the C29-BRs (Lee et al., 2011; Joo et al., 2015; Roh
et al., 2017; Kim et al., 2018).
Links Between C27-C28 and C28-C29
Pathways
The C27-BRs biosynthetic pathway links with the C28 pathway
through the following reactions: 28-norTE ! TE, 28-nor-3-DT
! 3-DT, 28-norTY ! TY, and 28-norCS ! CS. On the other
hand, C29-BRs conversion to C28-BRs occurs through the
following reactions: 28-homoTE ! TE, 28-homoTY ! TY,Frontiers in Plant Science | www.frontiersin.org 528-homoCS ! CS, 28-homoDS ! CS, and 28-homoDS ! DS
! CS. Therefore, it is suggested that the biosynthetic connection
of C27- and C29-BRs with C28-BRs occurs mainly between the
end products of the pathways. Five pathways are biosynthetically
connected to produce CS, an active BR, in plants (Figure 1;
Figure S1). Direct substrates to synthesize CS are: 28-norCS, DS,
6-deoxoCS by 6a-hydroxyCS, 28-homoDS, and 28-homoCS.
Thus, it is most conceivable that all the biosynthetic pathways
of BRs in plants are funneled into CS to carry out the relevant
biological activities. It is known that the early C-6 oxidation
pathways of C27-, C28-, and C29-BRs are commonly interrupted
in plant tissues (Fujita et al., 2006; Joo et al., 2012; Joo et al., 2015;
Kim et al., 2018). A recent study of barley (Hordeum vulgare) BR
mutants indicated that the accumulation of 28-homoCS is
inversely correlated with the accumulation of CS: mutants
deficient in the biosynthesis of CS accumulate the highest
concentrations of 28-homoCS, on the other hand, the BR-
insensitive line, in which the highest concentration of CS was
observed, accumulates the lowest concentration of 28-homoCS
(Gruszka et al., 2016).INHIBITORS OF BR BIOSYNTHESIS
Inhibitors are tools useful not only for investigating biosynthetic
pathways, but also for manipulating the BR level in crop plants. Till
now, 17 inhibitors (KM-01, brassinozole (Brz), Brz2001, Brz220,
propiconazole, YCZ-18, yucaizol, fenarimol, spironolactone,
triadimefon, imazalil, 4-MA, VG106, DSMEM21, finastride,
AFA76, and brassinopride) have been discovered (Figure 2),
however, the site of action of only nine compounds is known.
The sites of action of inhibitors are as follows:
• campestanol ! 6-deoxoCT for brassinazole, Brz2001,
Brz220, triadimefon, and spironolactone;
• 6-deoxoCT! 6-deoxoTE for brassinazole, Brz2001, Brz220,
propiconazole, and fenarimol;
• 6-deoxoTE ! 6-deoxo-3DT for YCZ-18, yucaizol,
propiconazole, and fenarimol;
• 6-oxocampestanol ! CT for brassinazole, Brz2001, Brz220,
and triadimefon;
• CT ! TE for brassinazole, Brz2001, Brz220, propiconazole,
and fenarimol;
• TE ! 3DT for YCZ-18, yucaizol, propiconazole, and
fenarimol (Rozhon et al., 2019) (Figure 1; Figure S1).
The first reported BR inhibitor, i.e., KM-01 was isolated from
a microbial culture medium. It inhibited BR activity in a rice
lamina inclination test. Despite the unclear site of action, KM-01
exhibits highly potent activity (Kim et al., 1994; Kim et al., 1995;
Kim et al., 1998). However, brassinazole (Brz) represents the first
specific BR biosynthesis inhibitor, which blocks the conversion
of campestanol to 6-deoxoCT, 6-deoxoCT to 6-deoxoTE, 6-
oxocampestanol to CT, and CT to TE in the BR biosynthetic
pathways. Brz2001 is a modified form of Brz containing an allyl
moiety instead of the methyl group. Both inhibitors block theJuly 2020 | Volume 11 | Article 1034
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Asami et al., 2001; Asami et al., 2003b). Brz and Brz2001 can
induce morphological changes, including dwarfism, altered leaf
color, and curling in de-etiolated barley (Sekimata et al., 2001).
Brz decreased the level of BRs in the barley leaves, but not in
roots. The inhibition effect of Brz on plant growth is reversed by
exogenous BR (Bajguz and Asami, 2004; Bajguz and Asami,
2005; Bajguz et al., 2019).
Propiconazole, a triazole compound, also affects similar to Brz
(Hartwig et al., 2012). Another triazole-type BR biosynthesis
inhibitors, YCZ-18, and yucaizol, bind to the CYP90D1 enzyme
and inhibit the BR-induced cell elongation. However, only BL
negates the inhibitory effect of YCZ-18 or yucaizol. Therefore, it
was suggested that they function differently from Brz (Oh et al.,
2015a; Oh et al., 2015b). Fenarimol is known for inhibiting
cytochrome P450 monoxides involved in 14a-demethylation
during the biosynthesis of ergosterol. Simultaneously, it
inhibits the conversion of CT to TE, and evokes the phenotype
of BR-deficient mutants with short hypocotyls, de-etiolate dark-
grown seedlings, and dark green downward curled leaves of
light-grown A. thaliana (Wang et al., 2001; Oh et al., 2015a).
Plants treated with triadimefon show reduced elongation of
stems and petioles, dark green and thicker leaves, delayed
senescence, and increased expression levels of the CPD gene.
The phenotypes could be recovered with CT, TE, TY, CS, and BL
(Asami et al., 2003a). On the other hand, imazalil causes severe
hypocotyl shortening in A. thaliana, which could be reversed byFrontiers in Plant Science | www.frontiersin.org 7the application of 24-epibrassinolide (Werbrouck et al., 2003).
Seedlings of A. thaliana treated with spironolactone showed
dark, downward curled leaves, and shortened hypocotyls,
which could be reversed by BL application (Asami et al., 2004).
Although A. thaliana mutants viz. cpd, det2-1, or cbb1 treated
with brassinopride enhanced apical hook formation, the normal
phenotype was recovered by BL (Gendron et al., 2008).
Voriconazole, fluconazole, and fenproprimorph (Figure 2)
inhibit cycloeucalenol-obtusifoliol isomerase and have a
reductive impact on BRs level (Rozhon et al., 2013; Rozhon
et al., 2019).AUTHOR CONTRIBUTIONS
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